Trial intelligence / Profile preview

Khat for Eyelid Wound Healing After Oculoplastic Surgery

NCT03917641Unknown

Sponsor
Sheba Medical Center
Start
Jul 2019
Primary completion
Jul 2020
Modality
PE (Plant Extract)
Countries
1
01

Overview

Open-label trial of khat in edema and hematoma, sponsored by Sheba Medical Center. Primary endpoints: Edema at 7 days and Hematoma at 7 days. Status: unknown.

02

Drugs

khat
03

Conditions

edemahematoma

Beyond the preview

Go deeper on NCT03917641.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03917641.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call